Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nirogacestat in Kaposi Sarcoma
NCT07539454Phase 2Recruiting
- Sponsor
- AIDS Malignancy Consortium
- Start
- Oct 2026
- Primary completion
- Feb 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nirogacestat in Kaposi sarcoma (KS), sponsored by AIDS Malignancy Consortium. Started Oct 2026; status: recruiting.
02
Drugs
nirogacestat
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT07539454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07539454.